Stock·NASDAQ·Consumer Cyclical
Five Below, Inc. (FIVE)
- Market cap
- $12.26B
- P/E
- 19.50
- Dividend yield
- 0.00%
- Street target
- $300.00median of 26 analysts
- 52-week range
- $143.02 $263.88
The short version
Where FIVE stands today, in four lines, and what CleaRank Financial AI makes of it.
FIVE at a glance
Five Below, Inc. (FIVE): Buy, 67/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($216.24 and $234.40).
- Earnings FIVE beat estimates in 4 of its last 4 quarters, and the stock rose the next day every time.
- Insiders Insiders sold $25.9M and bought $93K over the last 18 months.
- Valuation P/E of 19.5 against 20.8 for the Consumer Cyclical sector: broadly in line with peers (-6%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates Five Below, Inc. (FIVE) Buy, with a model score of 67/100.
The analysts' outlook pushes the score up the most: 17 of 26 analysts rate the stock a buy, and the median target is 34.7% above the price. Momentum pulls it down the most, since the MACD line is negative. The trend is mixed, with the stock 4.98% under its 50-day average of $234.40 but 3.00% over its 200-day average of $216.24. Over the past year, the price climbed 46.56%.
Only on CleaRank
Figures we compute ourselves from FIVE's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $222.72 is 5.0% below the 50-day simple moving average of $234.40.Price above its 200-day average ›
The price is 3.0% above the 200-day simple moving average of $216.24.50-day average above the 200-day ›
The 50-day average ($234.40) is 8.4% above the 200-day average ($216.24), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 66% of its 52-week range, between $143.02 and $263.88.
FIVE share price
Pick a period: each tab shows how far FIVE has moved over it, to the last close.
Today's trading
Where FIVE sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/4P/E below the sector median ›
The trailing P/E of 19.50 is 6.3% below the Consumer Cyclical median of 20.8.P/S below the sector median ›
The price-to-sales ratio of 2.31 is 21.7% above the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $619.2M on revenue of $5.3B, a net margin of 11.7%.Beat estimates in most recent reports ›
FIVE beat the EPS estimate in 4 of its last 4 reports.
Key statistics
The headline figures for FIVE.
As of October 17, 2026, FIVE trades at $222.72, with a market value of $12.26B and a P/E ratio of 19.50.
What the numbers say
CleaRank Financial AI's reading of FIVE's valuation, growth and risks.
FIVE trades at 19.50 times trailing earnings, which is 6.3% under the Consumer Cyclical median of 20.8. The peer comparison on this page calls that P/E broadly in line with peers. Its price-to-sales ratio of 2.31 is 21.6% higher than the sector median of 1.9. To put the size in context, the market capitalisation is $12.3B.
FIVE is growing faster than its sector: revenue rose 22.90% in the latest year, compared with a sector median of 7.2%. Its net margin stands at 11.65% and its operating margin at 8.86%. Return on equity, a measure of how well shareholders' capital is used, is 28.25%, above the sector median of 12.4%. Debt-to-equity sits at 0.82.
The most recent available report in our data for FIVE, dated December 3, 2025, beat the estimate by 161.54%. EPS came in at $0.68, against the $0.26 that analysts had expected. In the first session after the report, the share price rose 3.23%.
The record is a clean sweep: 4 beats in 4 reports, and every one of those beats was followed by a gain the next day. Looking ahead, analysts expect EPS of $10.25 this fiscal year (growth of 53.6%) and $11.06 the year after (growth of 8.0%).
Day-to-day swings are the first thing to plan around. On an average session, FIVE moves 2.02%. The price sits 15.60% below its 52-week high of $263.88. Over the last 18 months, insiders sold $25.9M of stock and bought $93K. Insider sales are often planned in advance or made to cover taxes on vesting shares, so they carry less weight than open-market purchases would.
FIVE against the Consumer Cyclical sector
How FIVE compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-6% difference), suggesting fair market pricing relative to industry standards.
Return vs SPY: Since May 6, 2025, FIVE has gained 174.9% against a gain of 36.6% for SPY.
Performance against SPY
FIVE and the Consumer Cyclical sector fund over the same days.
Revenue and earnings
How much FIVE sells, and how much of it becomes profit.
Revenue growth: Revenue grew 22.9% in FY2026 to $4.8B, from $3.9B a year earlier.
Profit margin: The net margin was 7.5% in FY2026, up from 6.5% the year before.
Profitable: FIVE earned $359M in FY2026.
Earnings reality check
Did FIVE beat what analysts expected, and how did the stock react?
Earnings record: FIVE beat the analyst estimate in 4 of the last 4 quarters.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Dec 3, 2025after close | $0.26 | $0.68 | +161.54% | +3.23% | +8.59% |
| Aug 27, 2025after close | $0.63 | $0.81 | +28.57% | +3.89% | +5.81% |
| Jun 4, 2025after close | $0.83 | $0.86 | +3.61% | +5.59% | +3.13% |
| Mar 19, 2025after close | $3.37 | $3.48 | +3.26% | +0.69% | +2.98% |
Reports after December 3, 2025 are not yet in our data.
As of October 17, 2026, FIVE has beaten the analyst EPS estimate in 4 of its last 4 reported quarters and rose in the first trading session after every one of those beats; its most recent report in our data, on December 3, 2025, came in 161.54% above the estimate and the stock moved +3.23% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 49.5, in neutral territory.RSI above 50 ›
An RSI of 49.5 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of FIVE
The score, the reasoning behind it, and what could move the price next.
Five Below, Inc. (FIVE) is showing a mixed trend. The stock changes hands at $222.72, which is 4.98% under its 50-day average of $234.40, yet it is 3.00% over its 200-day average of $216.24. The 50-day average sits 8.40% above the 200-day, so the moving averages have not yet adjusted to the softer price. Over the past year, the price is 55.73% above the 52-week low of $143.02 and 15.60% below the high of $263.88.
A recent pullback sits inside a stronger longer record: the price fell 6.29% over the past month, rose 9.91% over the past three months and rose 46.56% over the past year. The 14-day RSI of 49.5 is in the neutral zone, and the MACD line is negative.
Earnings beat ›
The December 3, 2025 report beat the EPS estimate by 161.54%, and the share price rose 3.23% in the first session after it.
Source: Earnings report, December 3, 2025
Rating reaffirmed ›
Evercore ISI Group kept its In-Line rating on September 29, 2026.
Source: Analyst action, Evercore ISI Group, September 29, 2026
- The two levels nearest the price matter most: the 50-day SMA at $234.40 sits above it, and the 20-day EMA at $221.24 sits below.
- The 14-day RSI is 49.5, in the neutral zone, and the MACD line is negative. Readings above 70 or below 30 would mark stretched momentum.
- After the December 3, 2025 report, the share price rose 3.23% in the first session. Across the last 4 reports, FIVE beat estimates in 4.
The trend is mixed: FIVE is above its 200-day average at $216.24 but below its 50-day average at $234.40. A close above the 50-day would turn both signals up, and a close below the 200-day would turn both down. The nearest levels are the 20-day EMA at $221.24 below and the 50-day SMA at $234.40 above.
Technical indicators
Momentum and trend for FIVE, from its daily closes.
As of October 17, 2026, with FIVE at $222.72, its 14-day RSI is 49.5 (neutral territory), its 50-day simple moving average is $234.40 and its 200-day is $216.24.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What FIVE moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, FIVE's 1-year correlation of daily returns is +0.41 with S&P 500 (SPY), +0.36 with Nasdaq 100 (QQQ), +0.11 with Bitcoin (BTC) and +0.02 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
17 of 26 analysts rate it a buy or strong buy, 9 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $300.00 is 34.7% above the price.More buy ratings than three months ago ›
17 of 26 rate it a buy now, against 17 of 25 three months ago.
FIVE Wall Street View
12-month price targets
The price, $222.72, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 29, 2026 | Evercore ISI Group | Maintains | In-Line |
| Sep 4, 2026 | Goldman Sachs | Maintains | Buy |
| Sep 3, 2026 | JP Morgan | Maintains | Overweight |
| Sep 3, 2026 | Jefferies | Maintains | Buy |
| Sep 3, 2026 | Telsey Advisory Group | Maintains | Outperform |
| Sep 3, 2026 | Evercore ISI Group | Maintains | In-Line |
As of October 17, 2026, 26 Wall Street analysts cover FIVE: 17 rate it a buy or strong buy, 9 a hold and 0 a sell or strong sell. Their 12-month price targets range from $226.00 to $420.00, with a median of $300.00, 34.7% above the price of $222.72.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
FIVE trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from FIVE's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much FIVE tends to move, against the market and on its own.
The long record
FIVE's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 2.02% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 75.5%, from August 2021 to April 2025, regained by March 2026.Most 1-year holds ended higher ›
66% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $61,678, against $42,055 in the S&P 500 (SPY).
FIVE Drawdowns & Recovery
As of October 17, 2026, FIVE's worst peak-to-trough fall over the last 10 years with dividends reinvested was -75.5% (August 2021 to April 2025); it regained that peak by March 2026, 11 months after the low, and 66% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into FIVE in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: FIVE beat the S&P 500 over this period: $61,678 against $42,055.
A $10,000 investment in FIVE in October 2016 would be worth about $61,678 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to FIVE, and which have not.
Strongest month, December: an average of +5.65%, up in 7 of 10 years.
Weakest month, March: an average of -3.95%, up in 4 of 10 years.
This month, October: has averaged +3.21%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, FIVE's strongest calendar month has been December (average +5.65%, up in 7 of 10 years) and its weakest March (average -3.95%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in FIVE, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in FIVE today could grow to about $26,498 by 2036 in the base case, with a 90th-percentile outcome near $177,098 and a 10th-percentile outcome around $3,965. Projections are statistical simulations, not guarantees.
FIVE Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $329 for FIVE by 2030 in the base case, from $223 today (1.5x over 4 years). The 10th-percentile path ends near $98.92. These are outcomes of a Monte Carlo simulation run on FIVE's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $135 | $246 | $448 | |
| 2028 | $116 | $271 | $633 | |
| 2029 | $105 | $298 | $844 | |
| 2030 | $98.92 | $329 | $1,093 | |
| 2031 | $94.63 | $363 | $1,389 |
Method: a lognormal simulation of FIVE's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
FIVE insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $93K on the open market and sold $25.9M.
As of October 17, 2026, FIVE insiders reported 21 open-market sales worth $25.9M and 1 open-market purchase worth $93K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Scott M Settersten
Director
|
Grant | 545 | - |
| Sep 14, 2026 | Eric M Specter
Officer
|
Sell | 5.5K | $1.4M |
| Sep 10, 2026 | Jacob Kimball Hawkins
Officer
|
Sell | 818 | $203.6K |
| Sep 10, 2026 | Dinesh S Lathi
Director
|
Grant | 110 | - |
| Sep 9, 2026 | Maureen Marie Gellerman
Officer
|
Sell | 1.6K | $400.8K |
| Sep 4, 2026 | Kenneth R Bull
Chief Operating Officer
|
Sell | 10.5K | $2.6M |
| Sep 4, 2026 | Michael F Devine III
Director
|
Sell | 4.3K | $1.1M |
| Aug 3, 2026 | Dinesh S Lathi
Director
|
Grant | 138 | $29.9K |
| Aug 3, 2026 | Richard L Markee
Director
|
Grant | 97 | $21.0K |
| Aug 3, 2026 | Mimi Eckel Vaughn
Director
|
Grant | 96 | $20.8K |
| Jun 29, 2026 | Robert Lynch
Director
|
Buy | 530 | $93.3K |
| Jun 22, 2026 | Rodney Lastinger
Officer
|
Grant | 3.6K | - |
| Jun 16, 2026 | Karen R Bowman
Director
|
Grant | 976 | - |
| Jun 16, 2026 | Michael F Devine III
Director
|
Grant | 1.7K | - |
| Jun 16, 2026 | Dinesh S Lathi
Director
|
Grant | 976 | - |
| Jun 16, 2026 | Robert Lynch
Director
|
Grant | 976 | - |
| Jun 16, 2026 | Richard L Markee
Director
|
Grant | 976 | - |
| Jun 16, 2026 | Mimi Eckel Vaughn
Director
|
Grant | 976 | - |
| Jun 16, 2026 | Zuhairah Scott Washington
Director
|
Grant | 976 | - |
| Jun 15, 2026 | Kenneth R Bull
Chief Operating Officer
|
Grant | 2.1K | - |
| Jun 15, 2026 | Maureen Marie Gellerman
Officer
|
Grant | 252 | - |
| Jun 15, 2026 | Amit Jhunjhunwala
Chief Technology Officer
|
Grant | 590 | - |
| Jun 15, 2026 | Graham Poliner
Officer
|
Grant | 252 | - |
| Jun 15, 2026 | Eric M Specter
Officer
|
Grant | 758 | - |
| Jun 15, 2026 | Christos George Yatrakis
Officer
|
Grant | 1.0K | - |
| May 4, 2026 | Dinesh S Lathi
Director
|
Grant | 134 | $31.0K |
| May 4, 2026 | Richard L Markee
Director
|
Grant | 96 | $22.2K |
| May 4, 2026 | Thomas M Ryan
Director
|
Grant | 96 | $22.2K |
| May 4, 2026 | Mimi Eckel Vaughn
Director
|
Grant | 96 | $22.2K |
| Mar 26, 2026 | Richard L Markee
Director
|
Sell | 3.0K | $696.1K |
| Mar 24, 2026 | Ronald L Sargent
Director
|
Sell | 20.0K | $4.6M |
| Mar 20, 2026 | Kenneth R Bull
Chief Operating Officer
|
Sell | 10.0K | $2.3M |
| Mar 19, 2026 | Kenneth R Bull
Chief Operating Officer
|
Grant | 6.2K | - |
| Mar 19, 2026 | Maureen Marie Gellerman
Officer
|
Grant | 1.1K | - |
| Mar 19, 2026 | Maureen Marie Gellerman
Officer
|
Grant | 1.2K | - |
| Mar 19, 2026 | Jacob Kimball Hawkins
Officer
|
Grant | 1.3K | - |
| Mar 19, 2026 | Michelle Lee Israel
Officer
|
Grant | 1.3K | - |
| Mar 19, 2026 | Amit Jhunjhunwala
Chief Technology Officer
|
Grant | 1.8K | - |
| Mar 19, 2026 | Amit Jhunjhunwala
Chief Technology Officer
|
Grant | 2.1K | - |
| Mar 19, 2026 | Winifred Park
Chief Executive Officer
|
Grant | 8.9K | - |
| Mar 19, 2026 | Graham Poliner
Officer
|
Grant | 1.3K | - |
| Mar 19, 2026 | Graham Poliner
Officer
|
Grant | 1.2K | - |
| Mar 19, 2026 | Eric M Specter
Officer
|
Grant | 2.6K | - |
| Mar 19, 2026 | Eric M Specter
Officer
|
Grant | 2.2K | - |
| Mar 19, 2026 | Daniel J Sullivan
Chief Financial Officer
|
Grant | 3.1K | - |
| Feb 2, 2026 | Kathleen S Barclay
Director
|
Grant | 112 | $22.2K |
| Feb 2, 2026 | Dinesh S Lathi
Director
|
Grant | 156 | $30.9K |
| Feb 2, 2026 | Richard L Markee
Director
|
Grant | 112 | $22.2K |
| Feb 2, 2026 | Thomas M Ryan
Director
|
Grant | 112 | $22.2K |
| Feb 2, 2026 | Mimi Eckel Vaughn
Director
|
Grant | 113 | $22.4K |
| Jan 15, 2026 | Kenneth R Bull
Chief Operating Officer
|
Sell | 7.0K | $1.4M |
| Jan 13, 2026 | Eric M Specter
Officer
|
Sell | 8.5K | $1.7M |
| Dec 15, 2025 | Kathleen S Barclay
Director
|
Sell | 2.2K | $400.5K |
| Dec 12, 2025 | George S Hill
Officer
|
Sell | 7.5K | $1.4M |
| Dec 11, 2025 | Michael F Devine III
Director
|
Sell | 6.0K | $1.1M |
| Dec 5, 2025 | Kenneth R Bull
Chief Operating Officer
|
Sell | 25.0K | $4.4M |
| Dec 5, 2025 | Maureen Marie Gellerman
Officer
|
Sell | 544 | $94.9K |
| Nov 3, 2025 | Kathleen S Barclay
Director
|
Grant | 141 | $22.3K |
| Nov 3, 2025 | Dinesh S Lathi
Director
|
Grant | 196 | $31.1K |
| Nov 3, 2025 | Richard L Markee
Director
|
Grant | 141 | $22.3K |
| Nov 3, 2025 | Thomas M Ryan
Director
|
Grant | 143 | $22.7K |
| Nov 3, 2025 | Mimi Eckel Vaughn
Director
|
Grant | 142 | $22.5K |
| Oct 6, 2025 | Michelle Lee Israel
Officer
|
Grant | 488 | - |
| Oct 6, 2025 | Daniel J Sullivan
Chief Financial Officer
|
Grant | 13.0K | - |
| Sep 30, 2025 | Kenneth R Bull
Chief Operating Officer
|
Grant | 644 | - |
| Sep 16, 2025 | Kenneth R Bull
Chief Operating Officer
|
Grant | 15.3K | - |
| Sep 16, 2025 | Maureen Marie Gellerman
Officer
|
Grant | 79 | - |
| Sep 16, 2025 | George S Hill
Officer
|
Grant | 596 | - |
| Sep 16, 2025 | Amit Jhunjhunwala
Chief Technology Officer
|
Grant | 291 | - |
| Sep 16, 2025 | Ronald James Masciantonio
General Counsel
|
Grant | 158 | - |
| Sep 16, 2025 | Graham Poliner
Officer
|
Grant | 79 | - |
| Sep 16, 2025 | Eric M Specter
Officer
|
Grant | 357 | - |
| Sep 4, 2025 | Ronald L Sargent
Director
|
Grant | 3.3K | - |
| Aug 29, 2025 | Ronald James Masciantonio
General Counsel
|
Sell | 818 | $119.8K |
| Aug 28, 2025 | George S Hill
Officer
|
Sell | 1.5K | $225.3K |
| Aug 4, 2025 | Kathleen S Barclay
Director
|
Grant | 170 | $23.2K |
| Aug 4, 2025 | Dinesh S Lathi
Director
|
Grant | 219 | $29.9K |
| Aug 4, 2025 | Richard L Markee
Director
|
Grant | 155 | $21.2K |
| Aug 4, 2025 | Thomas M Ryan
Director
|
Grant | 150 | $20.5K |
| Aug 4, 2025 | Mimi Eckel Vaughn
Director
|
Grant | 155 | $21.2K |
| Jul 17, 2025 | George S Hill
Officer
|
Sell | 1.5K | $210.0K |
| Jun 26, 2025 | Eric M Specter
Officer
|
Sell | 5.5K | $719.2K |
| Jun 16, 2025 | Amit Jhunjhunwala
Officer
|
Sell | 1.7K | $212.8K |
| Jun 12, 2025 | Kathleen S Barclay
Director
|
Grant | 1.4K | - |
| Jun 12, 2025 | Karen R Bowman
Director
|
Grant | 1.4K | - |
| Jun 12, 2025 | Michael F Devine III
Director
|
Grant | 2.6K | - |
| Jun 12, 2025 | Dinesh S Lathi
Director
|
Grant | 1.4K | - |
| Jun 12, 2025 | Richard L Markee
Director
|
Grant | 1.4K | - |
| Jun 12, 2025 | Thomas M Ryan
Director
|
Grant | 1.4K | - |
| Jun 12, 2025 | Ronald L Sargent
Director
|
Grant | 1.4K | - |
| Jun 12, 2025 | Mimi Eckel Vaughn
Director
|
Grant | 1.4K | - |
| Jun 12, 2025 | Zuhairah Scott Washington
Director
|
Grant | 1.4K | - |
| Jun 5, 2025 | George S Hill
Officer
|
Sell | 4.5K | $598.2K |
| May 5, 2025 | Kathleen S Barclay
Director
|
Grant | 343 | $28.4K |
| May 5, 2025 | Dinesh S Lathi
Director
|
Grant | 375 | $31.0K |
| May 5, 2025 | Richard L Markee
Director
|
Grant | 270 | $22.4K |
| May 5, 2025 | Thomas M Ryan
Director
|
Grant | 268 | $22.2K |
| May 5, 2025 | Mimi Eckel Vaughn
Director
|
Grant | 270 | $22.4K |
| May 5, 2025 | Thomas G Vellios
Officer and Director
|
Grant | 513 | $42.5K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.